Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07435766 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Iron Absorption From IFA and MMS Supplements in Kenyan Women During the Second Trimester of Pregnancy

Study acronym: PROUD
StatusRecruiting
PhaseNot applicable
SponsorETH Zurich
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 27, 2026 (before its estimated July 31, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Minor Study First Submitted
15 trials monitored
See 1 trial at risk
This study evaluates iron absorption from three antenatal supplements, 30 mg MMS, 60 mg MMS, and 60 mg IFA, in 50 pregnant Kenyan women in their second trimester. Using a randomized crossover design and stable iron isotopes, we will compare bioavailability in both fasted and fed states. Additionally, the trial will investigate if daily dosing triggers a hepcidin response that inhibits subsequent absorption, testing whether alternate-day dosing is a more effective strategy for treating iron deficiency.
Trial Details
NCT Number NCT07435766
Lead Sponsor ETH Zurich
Conditions
(from sponsor)
Pregnancy
Related terms Iron Deficiencies
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov